Concepedia

Michael Salcius

MS

Statistics

Publications

13

Citations

1.3K

H-Index

12

Active since

2003

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Yale University

Novartis (China)

Michael Salcius is an author at Novartis (United States) specializing in life sciences, molecular biology, and gene expression.

Publications per year

2003–2025

13

Publications

13

SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice

James Palacino, Susanne E. Swalley, Cheng Song et al. · Nature Chemical Biology · 2015 · 428 citations

Life Sciences, Molecular Biology, Molecular Genetics +12

Analyzing antibody specificity with whole proteome microarrays

Gregory A. Michaud, Michael Salcius, Fang Zhou et al. · Nature Biotechnology · 2003 · 275 citations

Life Sciences, Immunology, Molecular Biology +12

Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer

Agustı́n Rodrı́guez-González, Kedra Cyrus, Michael Salcius et al. · Oncogene · 2008 · 209 citations

Life Sciences, Molecular Biology, Oncology +14

DcpS as a Therapeutic Target for Spinal Muscular Atrophy

J. J. Singh, Michael Salcius, Shin-Wu Liu et al. · ACS Chemical Biology · 2008 · 132 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma

Nathan T. Ross, Felix Lohmann, Seth Carbonneau et al. · Nature Chemical Biology · 2019 · 89 citations · Full text

Medicine, Molecular Biology, Oncology +15

1–5 of 13